{"id":"NCT01318135","sponsor":"Takeda","briefTitle":"Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan","officialTitle":"A Long-term, Open-label Extension Study to Investigate the Long-term Safety of Alogliptin When Used in Combination With Sulfonylurea or Metformin in Subjects With Type 2 Diabetes in Japan","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2009-01","primaryCompletion":"2010-01","completion":"2010-04","firstPosted":"2011-03-18","resultsPosted":"2012-08-16","lastUpdate":"2012-08-16"},"enrollment":576,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Alogliptin and glimepiride","otherNames":["SYR-322","Amaryl"]},{"type":"DRUG","name":"Alogliptin and glimepiride","otherNames":["SYR-322","Amaryl"]},{"type":"DRUG","name":"Alogliptin and metformin","otherNames":["SYR-322","Glycoran"]},{"type":"DRUG","name":"Alogliptin and metformin","otherNames":["SYR-322","Glycoran"]}],"arms":[{"label":"Alogliptin 12.5 mg QD and Glimepiride 1- 6 mg QD or BID","type":"ACTIVE_COMPARATOR"},{"label":"Alogliptin 25 mg QD and Glimepiride 1 - 6 mg QD or BID","type":"ACTIVE_COMPARATOR"},{"label":"Alogliptin 12.5 mg QD and Metformin 500 mg BID or 750 mg TID","type":"ACTIVE_COMPARATOR"},{"label":"Alogliptin 25 mg QD and Metformin 500 mg BID or 750 mg TID","type":"ACTIVE_COMPARATOR"}],"summary":"To evaluate the efficacy and safety of alogliptin administered as an add-on to sulfonylurea (glimepiride) or metformin, once daily (QD), twice daily (BID) or three times daily (TID).","primaryOutcome":{"measure":"Number of Participants With Adverse Events.","timeFrame":"52 Weeks.","effectByArm":[{"arm":"Alogliptin 12.5 mg QD and Glimepiride 1- 6 mg QD or BID","deltaMin":16,"sd":null},{"arm":"Alogliptin 25 mg QD and Glimepiride 1 - 6 mg QD or BID","deltaMin":3,"sd":null},{"arm":"Alogliptin 12.5 mg QD and Metformin 500 mg BID or 750 mg TID","deltaMin":7,"sd":null},{"arm":"Alogliptin 25 mg QD and Metformin 500 mg BID or 750 mg TID","deltaMin":5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["24843617"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":150},"commonTop":["Nasopharyngitis","Upper respiratory tract inflammation","Back pain","Constipation","Diabetic retinopathy"]}}